(Q45892920)

English

Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy

scientific article published on 4 November 2015

Statements

Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit